By: John Rother The problem of unaffordable prescription drug prices is not a simple on, nor is there a single policy that addresses the full range of issues. We need to fix the current broken system to make drugs more affordable while maintaining incentives to discover important new cures. There are seven “deadly sins” that now characterize […]
Now is the Time to Lower Prescription Drug Prices
By John RotherBlog post from January 7, 2018 There were two big stories from the pharmaceutical industry this week, both reported by the Wall Street Journal: 1) Bristol-Myers Squibb intends to acquire Celgene in a $74 billion dollar deal; and 2) drug manufacturers have already hiked prices for hundreds of medicines for 2019. Both stories […]
Takeaways from a year of health care disruption
With 2018 now underway, the National Coalition on Health Care has been reflecting on the tumult of the past year and what we have learned. There has been so much going on in health care and health policy, much of it negative, that it’s difficult to form a simple assessment of the possible impact going forward. Here are ten significant observations as I reflect back on 2017.
Deadlines loom for key components to addressing U.S. primary care shortage
Sustaining a strong and resilient primary care workforce is essential to improving patient access to care and winning the battle against chronic disease—the central threat to health care affordability. The impact of the primary care shortage on both providers and patients has been huge, and lessening this impact must continue to be a federal priority beyond September 30th.
It’s time for Congress to shift focus from cost-shifting to cost-saving
Congress should give up the latest attempt to revive fundamentally flawed repeal legislation. It is time to refocus on ways to actually slow the growth of health costs rather than simply shifting them to patients and states.
- 1
- 2
- 3
- …
- 10
- Next Page »